These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 17695539

  • 1. Immunophenotypic profile of biomarkers related to anti-apoptotic and neural development pathways in the Ewing's family of tumors (EFT) and their therapeutic implications.
    Navarro S, Giraudo P, Karseladze AI, Smirnov A, Petrovichev N, Savelov N, Alvarado-Cabrero I, Llombart-Bosch A.
    Anticancer Res; 2007; 27(4B):2457-63. PubMed ID: 17695539
    [Abstract] [Full Text] [Related]

  • 2. A general aspect on soft-tissue sarcoma and c-kit expression in primitive neuroectodermal tumor and Ewing's sarcoma. Is there any role in disease process?
    Kara IO, Gonlusen G, Sahin B, Ergin M, Erdogan S.
    Saudi Med J; 2005 Aug; 26(8):1190-6. PubMed ID: 16127511
    [Abstract] [Full Text] [Related]

  • 3. Expression of c-kit in Ewing family of tumors: a comparison of different immunohistochemical protocols.
    Ahmed A, Gilbert-Barness E, Lacson A.
    Pediatr Dev Pathol; 2004 Aug; 7(4):342-7. PubMed ID: 15383930
    [Abstract] [Full Text] [Related]

  • 4. C-kit receptor expression in Ewing's sarcoma: lack of prognostic value but therapeutic targeting opportunities in appropriate conditions.
    Scotlandi K, Manara MC, Strammiello R, Landuzzi L, Benini S, Perdichizzi S, Serra M, Astolfi A, Nicoletti G, Lollini PL, Bertoni F, Nanni P, Picci P.
    J Clin Oncol; 2003 May 15; 21(10):1952-60. PubMed ID: 12743148
    [Abstract] [Full Text] [Related]

  • 5. Ewing's sarcoma and primitive neuroectodermal family of tumors.
    Carvajal R, Meyers P.
    Hematol Oncol Clin North Am; 2005 Jun 15; 19(3):501-25, vi-vii. PubMed ID: 15939194
    [Abstract] [Full Text] [Related]

  • 6. Assessment of muscarinic and nicotinic acetylcholine receptor expression in primitive neuroectodermal tumor/ewing family of tumor and desmoplastic small round cell tumor: an immunohistochemical and Western blot study of tissue microarray and cell lines.
    Schlauder SM, Steffensen TS, Morgan M, Letson DG, Pledger WJ, Ma L, Bui MM.
    Fetal Pediatr Pathol; 2008 Jun 15; 27(2):83-97. PubMed ID: 18568996
    [Abstract] [Full Text] [Related]

  • 7. Insulin-like growth factor I receptor-mediated circuit in Ewing's sarcoma/peripheral neuroectodermal tumor: a possible therapeutic target.
    Scotlandi K, Benini S, Sarti M, Serra M, Lollini PL, Maurici D, Picci P, Manara MC, Baldini N.
    Cancer Res; 1996 Oct 15; 56(20):4570-4. PubMed ID: 8840962
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Induction of cell death by basic fibroblast growth factor in Ewing's sarcoma.
    Sturla LM, Westwood G, Selby PJ, Lewis IJ, Burchill SA.
    Cancer Res; 2000 Nov 01; 60(21):6160-70. PubMed ID: 11085540
    [Abstract] [Full Text] [Related]

  • 12. Immunophenotype of desmoplastic small round cell tumors as detected in cases with EWS-WT1 gene fusion product.
    Zhang PJ, Goldblum JR, Pawel BR, Fisher C, Pasha TL, Barr FG.
    Mod Pathol; 2003 Mar 01; 16(3):229-35. PubMed ID: 12640103
    [Abstract] [Full Text] [Related]

  • 13. Ewing's sarcoma/peripheral primitive neuroectodermal tumor (ES/PNET) differentiation in endometrial serous carcinomas.
    Quddus MR, Rashid L, Sung CJ, Steinhoff MM, Cunxian Zhang, Lawrence WD.
    Reprod Sci; 2009 Jun 01; 16(6):591-5. PubMed ID: 19318687
    [Abstract] [Full Text] [Related]

  • 14. Fibroblast growth factor 2 induces differentiation and apoptosis of Askin tumour cells.
    Kim MS, Kim CJ, Jung HS, Seo MR, Juhnn YS, Shin HY, Ahn HS, Thiele CJ, Chi JG.
    J Pathol; 2004 Jan 01; 202(1):103-12. PubMed ID: 14694527
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-12 up-regulates Fas expression in human osteosarcoma and Ewing's sarcoma cells by enhancing its promoter activity.
    Zhou Z, Lafleur EA, Koshkina NV, Worth LL, Lester MS, Kleinerman ES.
    Mol Cancer Res; 2005 Dec 01; 3(12):685-91. PubMed ID: 16380506
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Expression of Fas and Fas-ligand in donor hematopoietic stem and progenitor cells is dissociated from the sensitivity to apoptosis.
    Pearl-Yafe M, Yolcu ES, Stein J, Kaplan O, Shirwan H, Yaniv I, Askenasy N.
    Exp Hematol; 2007 Oct 01; 35(10):1601-12. PubMed ID: 17889725
    [Abstract] [Full Text] [Related]

  • 18. Nucleophosmin as a candidate prognostic biomarker of Ewing's sarcoma revealed by proteomics.
    Kikuta K, Tochigi N, Shimoda T, Yabe H, Morioka H, Toyama Y, Hosono A, Beppu Y, Kawai A, Hirohashi S, Kondo T.
    Clin Cancer Res; 2009 Apr 15; 15(8):2885-94. PubMed ID: 19351769
    [Abstract] [Full Text] [Related]

  • 19. PKC-theta expression in Ewing sarcoma/primitive neuroectodermal tumour and malignant peripheral nerve sheath tumour.
    Kang GH, Kim KM, Park CK, Kang DY.
    Histopathology; 2009 Sep 15; 55(3):368-9. PubMed ID: 19723158
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.